[Ip-health] National Academies report

[Michael Selgelid]

This is a multi-part message in MIME format.
--
[ Picked text/plain from multipart/alternative ]


See:
http://view.newsletters.nas.edu/?j=fe8c10747d630d7f74&m=fefc1276756205&l
s=fe0416717660057c751d7574&l=fe9615727467037477&s=fe3416757767047e731674
&ju=fe60177172670c787510&utm_medium=etmail&utm_source=National%20Academi
es%20Press&utm_campaign=New+from+NAP+4.15.08-April-15-2008&utm_content=D
ownloader&utm_term=


Now available from National Academies Press:



Emerging Safety Science: Workshop Summary
<http://click.newsletters.nas.edu/?ju=fe5c177172670c78751c&ls=fe04167176
60057c751d7574&m=fefc1276756205&l=fe9615727467037477&s=fe3416757767047e7
31674&jb=ffcf14&t=>

In recent years, the costs of new drug development have skyrocketed. The
average cost of developing a new approved drug is now estimated to be
$1.3 billion (DiMasi and Grabowski, 2007). At the same time, each year
fewer new molecular entities (NMEs) are approved. DiMasi and Grabowski
report that only 21.5 percent of the candidate drugs that enter phase I
clinical testing actually make it to market. In 2007, just 17 novel
drugs and 2 novel biologics were approved.
More Information
<http://click.newsletters.nas.edu/?ju=fe5c177172670c78751c&ls=fe04167176
60057c751d7574&m=fefc1276756205&l=fe9615727467037477&s=fe3416757767047e7
31674&jb=ffcf14&t=>




This can be downloaded for free here:
http://books.nap.edu/catalog.php?record_id=11975&utm_medium=etmail&utm_s
ource=National%20Academies%20Press&utm_campaign=New+from+NAP+4.15.08-Apr
il-15-2008&utm_content=Downloader&utm_term=


----------
MICHAEL J. SELGELID
Senior Research Fellow
Centre for Applied Philosophy and Public Ethics (CAPPE)
Menzies Centre for Health Policy; and
National Centre for Biosecurity
The Australian National University

Email:   michael.selgelid@anu.edu.au
Office:  +61 (0)2 6125 4355
Mobile:  +61 (0)431 124 286
Fax:     +61 (0)2 6125 6579

Homepage:  http://www.cappe.edu.au/staff/michael-selgelid.htm

Mailing address:

CAPPE
LPO Box 8260
ANU Canberra ACT 2601
Australia